CVS Paying $36.5 Million for Overbilling Medi-Cal for Insulin Pens

Source Summary

CVS is paying $36.5 million for submitting false claims to the Medi-Cal program for excessive dispensing of insulin pens. A settlement pursued by California Attorney General Rob Bonta in collaboration with the United States Department of Justice with CVS Pharmacy, ...